Fasting, Longevity & mTOR

Part II


In the realm of fasting and its potential impact on longevity, understanding the role of mTOR (mammalian Target of Rapamycin) is essential. mTOR is a protein kinase that regulates various cellular processes, including growth, metabolism, and autophagy. It acts as a crucial switch that determines the balance between anabolic (building) and catabolic (breaking down) pathways in our bodies.

The Impact of mTOR Activation

mTOR activation occurs in response to various stimuli, with nutrient availability, especially amino acids (protein), being a potent trigger. When mTOR is activated, it promotes protein synthesis, cell growth, and tissue development. This is crucial for processes like muscle building and repair, as well as overall growth and development.

However, sustained and excessive mTOR activation can have adverse effects on longevity and health. It has been associated with increased cellular senescence, oxidative stress, inflammation, and the development of age-related diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders.

Fasting as an mTOR Regulator

One of the key benefits of fasting for longevity is its ability to regulate mTOR activity. By abstaining from food for specific periods, we can strategically modulate mTOR signaling and promote a balance between anabolic and catabolic processes.

During fasting, when nutrient availability is limited, mTOR activity is suppressed. This reduction in mTOR signaling triggers a cascade of events that promote cellular resilience and longevity. Here are some of the mechanisms associated with fasting and mTOR regulation:

Autophagy Promotion: Autophagy is a cellular process that involves the recycling and removal of damaged or dysfunctional components. Fasting induces autophagy by inhibiting mTOR, allowing cells to cleanse themselves of accumulated waste, toxins, and malfunctioning organelles. This process plays a crucial role in cellular rejuvenation and can potentially slow down the aging process.

Enhanced Stress Resistance: Fasting-induced mTOR inhibition activates stress response pathways, such as the AMP-activated protein kinase (AMPK) and sirtuin pathways. These pathways enhance cellular stress resistance, improve mitochondrial function, and promote the body’s ability to adapt and cope with stressors. By bolstering these mechanisms, fasting can potentially increase lifespan and reduce the risk of age-related diseases.

Metabolic Flexibility: Fasting trains our bodies to become metabolically flexible, allowing us to efficiently switch between different fuel sources. When mTOR is inhibited during fasting, our bodies shift from relying on glucose (sugar) to utilizing stored fat as an energy source. This metabolic adaptation has been associated with improved insulin sensitivity, reduced inflammation, and enhanced overall metabolic health.

Stem Cell Activation: Fasting has shown to stimulate the activation and regeneration of stem cells, which play a vital role in tissue repair and rejuvenation. mTOR inhibition during fasting enhances the self-renewal capacity of stem cells, enabling them to replenish and repair damaged tissues more effectively.

Longevity Pathway Activation: Fasting activates various longevity-promoting pathways, such as the insulin/IGF-1 signaling pathway and the sirtuin pathway. These pathways regulate cellular metabolism, oxidative stress, and DNA repair, contributing to enhanced cellular function and increased lifespan.

Incorporating Fasting for Longevity

To harness the potential longevity benefits of fasting and mTOR regulation, it is important to adopt a structured approach. Here are a few fasting strategies to consider:

Time-Restricted Eating: Implement daily fasting periods by restricting your eating window to 8-10 hours, allowing for a 14-16 hour fasting period. This approach provides the body with regular energy and nutrient intake, while still allowing for the benefits of daily fasting.

Intermittent Fasting: Incorporate intermittent fasting into your routine by having designated days with longer fasting periods. This can range from 16 to 24 hours of fasting, once or twice a week. During these fasting periods, mTOR activity is reduced, promoting cellular rejuvenation and longevity.

Extended Fasts: Consider longer fasting periods of 48 to 72 hours or even more, but only under the guidance of a healthcare professional. Extended fasting allows for deeper autophagy and cellular repair, providing potential benefits for longevity. However, it is important to approach extended fasting with caution and ensure proper hydration and nutrient replenishment.

Nutrient Timing: During your eating window, pay attention to the composition and quality of your meals. To optimize mTOR regulation and longevity, focus on consuming nutrient-dense whole foods, including adequate protein for muscle repair and synthesis.

Personalization and Consistency: Keep in mind that individual responses to fasting can vary. It is important to listen to your body and personalize your fasting approach accordingly. Consistency is also key. Make fasting a regular part of your lifestyle rather than a sporadic practice to reap the long-term benefits.


Understanding the intricate relationship between fasting, longevity, and mTOR provides valuable insights into the potential benefits of incorporating fasting into our lives. By strategically modulating mTOR activity through fasting, we can promote cellular resilience, enhance stress resistance, and activate pathways associated with longevity.

However, it is important to note that fasting alone is not a magic solution for longevity. It should be approached as part of a comprehensive lifestyle that includes a balanced diet, regular exercise, adequate sleep, and stress management. As always, it is advisable to consult with a healthcare professional before making any significant changes to your diet or lifestyle, especially if you have underlying health conditions.

In the next part of this comprehensive guide, we will explore the impact of fasting on metabolic health and discuss practical tips for incorporating fasting into your daily routine. Stay tuned for Part III: Fasting and Metabolic Health.


  • Fontana, L., Partridge, L., & Longo, V. D. (2010). Extending healthy life span–from yeast to humans. Science, 328(5976), 321-326.
  • Mattson, M. P., & Wan, R. (2005). Beneficial effects of intermittent fasting and caloric restriction on the cardiovascular and cerebrovascular systems. The Journal of nutritional biochemistry, 16(3), 129-137.
  • Madeo, F., Pietrocola, F., Eisenberg, T., & Kroemer, G. (2018). Caloric restriction mimetics: towards a molecular definition. Nature Reviews Drug Discovery, 17(12), 835-856.
  • Blagosklonny, M. V. (2013). Answering the ultimate question” what is the proximal cause of aging?”. Aging (Albany NY), 5(4), 259-263.
  • Lee, C., Safdie, F. M., Raffaghello, L., Wei, M., Madia, F., Parrella, E., … & Cohen, P. (2010). Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer research, 70(4), 1564-1572.
  • Kalaany, N. Y., & Sabatini, D. M. (2009). Tumours with PI3K activation are resistant to dietary restriction. Nature, 458(7239), 725-731.
  • Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., … & Sabatini, D. M. (2012). Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science, 335(6076), 1638-1643.
  • Heilbronn, L. K., de Jonge, L., Frisard, M. I., DeLany, J. P., Larson-Meyer, D. E., Rood, J., … & Ravussin, E. (2006). Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA, 295(13), 1539-1548.
  • Johnson, J. B., Summer, W., Cutler, R. G., Martin, B., Hyun, D. H., Dixit, V. D., … & Pearson, M. (2007). Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radical Biology and Medicine, 42(5), 665-674.
  • Blagosklonny, M. V. (2012). TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death & Disease, 3(7), e333.